4,6-Dichloro-N-Trideuteromethylpyridazine-3-Carboxamide: A Vital Pharmaceutical Intermediate
Unlock breakthroughs in drug development with this advanced chemical building block.
Get a Quote & SampleProduct Core Value
4,6-Dichloro-N-Trideuteromethylpyridazine-3-Carboxamide
This compound is a critical intermediate used in organic synthesis and pharmaceutical research. Its unique structure, including the pyridazine ring and the deuterium-labeled methyl group, is instrumental in the development of new drug candidates, offering potential improvements in bioavailability and metabolic stability.
- Explore the benefits of trideuteromethyl group integration for enhanced pharmacokinetics and metabolic stability in drug development.
- Leverage this compound as a key building block in organic synthesis to create novel chemical entities for various applications.
- Discover the potential of CAS 1609393-89-6 applications in advancing medicinal chemistry and creating targeted therapies.
- Source high purity chemical intermediates essential for robust pharmaceutical research and reliable drug development processes.
Key Advantages Offered
Advanced Pharmaceutical Synthesis
Utilize this compound as a crucial starting material for the synthesis of novel drug candidates, as highlighted in Deucravacitinib intermediate supplier networks.
Enhanced Drug Properties
The presence of the trideuteromethyl group can lead to improved pharmacokinetic profiles and metabolic stability, crucial for effective drug development.
Versatile Chemical Applications
Its structure makes it a valuable component in various organic synthesis pathways, enabling the creation of diverse chemical entities.
Key Applications
Organic Synthesis
A fundamental building block for creating complex organic molecules and new chemical entities.
Pharmaceutical Research
Essential for the discovery and development of new therapeutic agents, supporting drug development.
Medicinal Chemistry
Used to explore structure-activity relationships and optimize drug candidates for specific therapeutic goals.
Deucravacitinib Intermediate
A critical component in the synthesis pathway of Deucravacitinib, a significant pharmaceutical compound.